Literature DB >> 17077427

Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis.

Bernadka Dubicka1, Sarah Hadley, Christopher Roberts.   

Abstract

BACKGROUND: Concern exists that antidepressants can cause suicidality in youths with depression. AIMS: To determine the pooled risk of self-harm and suicidal behaviour from randomised trials of newer antidepressants.
METHOD: A meta-analysis was carried out to calculate odds ratios for the combined data.
RESULTS: Self-harm or suicide-related events occurred in 71 of 1487 (4.8%) of depressed youths treated with antidepressants v. 38 of 1254 (3.0%) of those given placebo (fixed effects odds ratio 1.70, 95% CI 1.13-2.54, P=0.01). There was a trend for individual suicidal thoughts, attempts and self-harm to occur more often in youths taking antidepressants than in those given placebo, but none of these differences was statistically significant.
CONCLUSIONS: Antidepressants may cause a small short-term risk of self-harm or suicidal events in children and adolescents with major depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077427     DOI: 10.1192/bjp.bp.105.011833

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  25 in total

1.  Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Xianfeng Shi; Eun-Kee Jeong; Perry F Renshaw
Journal:  J Affect Disord       Date:  2011-08-09       Impact factor: 4.839

2.  Venlafaxine for major depression.

Authors:  Andrea Cipriani; John R Geddes; Corrado Barbui
Journal:  BMJ       Date:  2007-02-03

3.  Should young people be given antidepressants? Yes.

Authors:  Andrew Cotgrove
Journal:  BMJ       Date:  2007-10-13

4.  Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.

Authors:  Sebastian Schneeweiss; Amanda R Patrick; Daniel H Solomon; Colin R Dormuth; Matt Miller; Jyotsna Mehta; Jennifer C Lee; Philip S Wang
Journal:  Pediatrics       Date:  2010-04-12       Impact factor: 7.124

Review 5.  Depression in children and adolescents.

Authors:  Philip Hazell
Journal:  BMJ Clin Evid       Date:  2009-01-07

6.  Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats.

Authors:  Andrew E Arrant; Elizabeth Coburn; Jacob Jacobsen; Cynthia M Kuhn
Journal:  Neuropharmacology       Date:  2013-06-15       Impact factor: 5.250

7.  Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.

Authors:  Ian Goodyer; Bernadka Dubicka; Paul Wilkinson; Raphael Kelvin; Chris Roberts; Sarah Byford; Siobhan Breen; Claire Ford; Barbara Barrett; Alison Leech; Justine Rothwell; Lydia White; Richard Harrington
Journal:  BMJ       Date:  2007-06-07

8.  Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.

Authors:  Marco Solmi; Michele Fornaro; Edoardo G Ostinelli; Caroline Zangani; Giovanni Croatto; Francesco Monaco; Damir Krinitski; Paolo Fusar-Poli; Christoph U Correll
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

9.  Frequency of different anti-depressants associated with suicides and drug deaths.

Authors:  Gustav Drasch; Felicitas Dahlmann; Ludwig von Meyer; Gabriele Roider; Wolfgang Eisenmenger
Journal:  Int J Legal Med       Date:  2007-07-06       Impact factor: 2.686

10.  Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.

Authors:  Matthew Miller; V Pate; S A Swanson; D Azrael; A White; T Stürmer
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.